BIMI International Medical

BIMI International Medical, Inc. engages in the provision of healthcare products and services. It operates through the following segments: Wholesale Pharmaceuticals, Wholesale Medical Devices, Medical Services, and Retail Pharmacies. The Wholesale Pharmaceuticals segment includes supplying prescription and OTC medicines, TCM, healthcare supplies and sundry items to clinics, third party pharmacies, hospitals, and other drug vendors. The Wholesale Medical Devices segment distributes medical devices, including medical consumables to drug stores, private clinics, pharmaceutical dealers and hospitals. The Medical Services segment includes the hospitals acquired in 2021.The Retail Pharmacy segment sells prescription and OTC medicines, traditional Chinese medicines (“TCM”), healthcare supplies, and sundry items to retail customers through its directly-owned pharmacies and authorized retail stores. The company was founded on October 31, 2000 and is headquartered in Chongqing, China.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

BIMI International Medical, Inc. engages in the provision of healthcare products and services. It operates through the following segments: Wholesale Pharmaceuticals, Wholesale Medical Devices, Medical Services, and Retail Pharmacies. The Wholesale Pharmaceuticals segment includes supplying prescription and OTC medicines, TCM, healthcare supplies and sundry items to clinics, third party pharmacies, hospitals, and other drug vendors. The Wholesale Medical Devices segment distributes medical devices, including medical consumables to drug stores, private clinics, pharmaceutical dealers and hospitals. The Medical Services segment includes the hospitals acquired in 2021.The Retail Pharmacy segment sells prescription and OTC medicines, traditional Chinese medicines (“TCM”), healthcare supplies, and sundry items to retail customers through its directly-owned pharmacies and authorized retail stores. The company was founded on October 31, 2000 and is headquartered in New York, NY.

NEW YORK, May 22, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (the “Company”), a leading medical solutions provider, today announced its financial results for the three months ended March 31, 2023. The Company reported a significant decrease in net losses and notable improvements in working capital, underlining the ongoing success of its business strategy and operational effectiveness.

BIMI International Medical Inc. Announces First Quarter 2023 Financial Results

NEW YORK, April 20, 2023 (GLOBE NEWSWIRE) -- On April 18, 2023, BIMI International Medical Inc. (the “Company”) today announced that on April 18, 2023, the Company received a notification letter from The Nasdaq Stock Market LLC (“Nasdaq”) stating that, because the Company has not yet filed its Annual Report on Form 10-K for the period ended December 31, 2022 (the “Form 10-K”), the Company is no longer in compliance with Nasdaq Listing Rule 5250(c)(1). Nasdaq Listing Rule 5250(c)(1) requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission. The Nasdaq letter has no immediate effect on the listing of the Company's shares.

BIMI Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)

NEW YORK, April 19, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a healthcare products and services provider, today announced the results of the Company's 2023 Special Meeting of Shareholders held on April 13, 2023 at the offices of the Company, 15th Floor, 725 5th Avenue, New York, NY, 10022.

BIMI Announces Results of 2023 Special meeting of Shareholders.

NEW YORK, Dec. 13, 2022 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a healthcare products and services provider, today announced its entry into an Amendment to the Stock Purchase Agreement originally entered into as of April 9, 2021 (the “Amendment”) for the acquisition of Wuzhou Qiangsheng Hospital Co., Ltd., Suzhou Eurasia Hospital Co., Ltd. and Yunan Yuxi Minkang Hospital Co., Ltd. (collectively the "Hospitals”).

BIMI Announces Entry into a Material Definitive Agreement

BIMI intends to use a reverse-stock split to bring the company into compliance with listing requirements of The Nasdaq Capital Market.

BIMI Announces 1-for -10 Reverse Stock Split

NEW YORK, Dec. 08, 2022 (GLOBE NEWSWIRE) --   BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a healthcare products and services provider, today announced the sale of a $2 Million promissory note (the “Note”) to the Chairman of the Board of the Company, Mr. Fnu Oudom on December 6, 2022.

BIMI Announces Sale of $2 Million Promissory Note

NEW YORK, Aug. 22, 2022 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a healthcare products and services provider, today announced its financial results for the six months ended June 30, 2022.

BIMI Announces Second Quarter 2022 Financial Results

New York, July 15, 2022 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a healthcare products and services provider, today announced the results of the Company's 2022 Annual General Meeting of Stockholders (the “Annual Meeting”) held on July 13, 2022 at 11:00 a.m. (Beijing Time), at the offices of the Company, 9th Floor, Building 2, Chongqing Corporation Avenue, Yuzhong District, Chongqing, P. R. China.

BIMI Announces Results of 2022 Annual General Meeting of Stockholders

Transaction expected to expand business and fuel growth

BIMI Enters into Definitive Agreement to Acquire Phenix Bio Inc.

BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a healthcare products and services provider, announced that it will hold its annual meeting of shareholders on July 13, 2022 at 11:00 a.m. (local time) at the offices of the Company, 9th Floor, Building 2, Chongqing Corporation Avenue, Yuzhong District, Chongqing, P. R. China.

BIMI to Hold Annual Shareholder Meeting on July 13, 2022

Shares of small-cap penny stock BIMI International Medical Inc. (NASDAQ: BIMI) shares are trading higher after the company announced it entered a $5 million stock purchase agreement with chairman Fnu Oudom. Mr. Fnu Oudom agreed to purchase 12,500,000 shares of common stock of the Company for $.

Why BIMI International Medical Shares Are Trading Higher Today

NEW YORK, June 10, 2022 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a healthcare products and services provider, today announced that on June 9, 2022, the Company entered into a Stock Purchase Agreement with Mr. Fnu Oudom, the Chairman of the Board of the Company, for the sale of 12,500,000 shares of common stock of the Company for $5 million, subject to stockholder approval.

BIMI Announces Entering into a $5 million Stock Purchase Agreement

NEW YORK, May 20, 2022 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a healthcare products and services provider, today announced its financial results for the quarter ended March 31, 2022.

BIMI International Medical Announces First Quarter 2022 Financial Results

NEW YORK, May 18, 2022 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a healthcare products and services provider, today announced that on May 12, 2022, the Board of Directors of the Company appointed Mr. Fnu Oudom to serve as Chairman of the Board and President of the Company, effective immediately. On May 12, 2022, the Board also elected Ms. Sammi Earn Seok Ang as an independent director of the Company, effective immediately.

BIMI Announces Appointment of New Chairman and Independent Director

NEW YORK, May 12, 2022 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a healthcare products and services provider, today announced that it has appointed Mr. Fnu Oudom as a director of the Company effective May 9, 2022, to fill a vacancy that recently occurred as the result of the resignation of a director.

BIMI Announces Appointment of Mr. Fnu Oudom to Board of Directors

NEW YORK, April 18, 2022 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a healthcare products and services provider, today announced its financial results for the fiscal year ended December 31, 2021.

BIMI International Medical Inc. Announces Fiscal Year 2021 Financial Results

NEW YORK, Feb. 03, 2022 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a healthcare products and services provider, today announced that on February 1, 2022, the Company entered into an Amendment and Settlement Agreement to amend the Stock Purchase Agreement relating to the acquisition of Chaohu Zhongshan Minimally Invasive Hospital (“Zhongshan Hospital”) dated in December 2020. The Amendment reduces post-closing performance targets and payments and settles certain payments as a result of such amendment.

BIMI Announces Amendment to Stock Purchase Agreement of Chaohu Zhongshan Minimally Invasive Hospital

NEW YORK, Feb. 02, 2022 (GLOBE NEWSWIRE) --  BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a healthcare products and services provider, today announced a 1-for-5 reverse split of its common stock effective today at 5:00 PM EST. Beginning on February 3, 2022, the Company's common stock will trade on Nasdaq on a split adjusted basis.

BIMI Announces 1-for -5 Reverse Stock Split

NEW YORK, Dec. 21, 2021 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced that it has signed a stock purchase agreement with Bengbu Mali OB-GYN Hospital (the “Mali Hospital”), also known as Bengbu Mali Maternity Hospital.

BIMI International Medical Inc. Signs Stock Purchase Agreement With Bengbu Mali OB-GYN Hospital

The stock price of BIMI International Medical Inc. (NASDAQ: BIMI) increased by over 15% pre-market today. This is why it happened.

BIMI International Medical (BIMI) Stock: Why The Price Jumped Today

BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a healthcare products and services provider, today announced that it has entered into a Securities Purchase Agreement (the “SPA”) with two institutional investors (the “Holders”) to sell certain senior secured convertible notes of the Company in a private placement in the aggregate principal amount of $7,800,000 in the aggregate original principal amount of $6,500,000, representing an aggregate original issue discount of 20% (the “Convertible Notes”). The Convertible Notes do not bear interest except upon the occurrence of certain events of default.

BIMI International Medical Inc. Announces Pricing of $7.8 million Private Placement

Agriforce Growing Systems Ltd

IZEA

Are these penny stocks worth watching right now? The post 3 Penny Stocks That Retail Traders Are Buying Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

3 Penny Stocks That Retail Traders Are Buying Right Now

BIMI International Medical (NASDAQ: BIMI) is a leading healthcare services and products provider that recently announced its third-quarter financial for 2021 and went up by 60%.  How does top brass feel about this?

Bimi International up 60% after announcing third-quarter results

BIMI International Medical (BIMI) stock is on the rise Tuesday and we're diving into all the latest details about the company. The post BIMI Stock: 10 Things to Know About BIMI International Medical as Shares Rocket appeared first on InvestorPlace.

BIMI Stock: 10 Things to Know About BIMI International Medical as Shares Rocket

The stock price of Bimi International Medical Inc (NASDAQ: BIMI) increased by over 60% pre-market today. This is why it happened.

News for BIMI International Medical Stock (BIMI)